It has been suggested that NF-κB activation in cancers may be the result of either exposure to pro-inflammatory stimuli in the tumor microenvironment or mutational activation of upstream components in IκK-NF-κB signaling pathways [17]. Here, NFKB1 is linked to neoplasm.